Vivos Therapeutics (VVOS) Other Non-Current Assets (2019 - 2026)
Vivos Therapeutics (VVOS) reported Other Non-Current Assets of $254000.0 for Q1 2026, up 18.14% year-over-year from $215000.0 in Q1 2025, and up 11.4% quarter-over-quarter from $228000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 8 years of Other Non-Current Assets data on file, last reported at $254000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $254000.0, up 18.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $254000.0 (up 18.14% YoY), and the FY2025 annual result was $228000.0, up 5.56% from the prior year.
- Other Non-Current Assets climbed to $254000.0 in Q1 2026 per VVOS's latest filing, from $228000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $374000.0 in Q4 2022 and troughed at $211000.0 in Q3 2025.
- A 5-year average of $290705.9 and a median of $307000.0 in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets tumbled 30.19% in 2025, then climbed 18.14% in 2026.
- A 5-year view of Other Non-Current Assets shows it stood at $374000.0 in 2022, then decreased by 17.91% to $307000.0 in 2023, then slipped by 29.64% to $216000.0 in 2024, then increased by 5.56% to $228000.0 in 2025, then advanced by 11.4% to $254000.0 in 2026.
- Business Quant data shows VVOS's Other Non-Current Assets at $254000.0 in Q1 2026, $228000.0 in Q4 2025, and $211000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | 254,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 254,000.00 |
| Dec 31, 2025 | 228,000.00 |
| Sep 30, 2025 | 211,000.00 |
| Jun 30, 2025 | 255,000.00 |
| Mar 31, 2025 | 215,000.00 |
| Dec 31, 2024 | 216,000.00 |
| Sep 30, 2024 | 276,000.00 |
| Jun 30, 2024 | 276,000.00 |
| Mar 31, 2024 | 308,000.00 |
| Dec 31, 2023 | 307,000.00 |
| Sep 30, 2023 | 307,000.00 |
| Jun 30, 2023 | 308,000.00 |
| Mar 31, 2023 | 308,000.00 |
| Dec 31, 2022 | 374,000.00 |
| Sep 30, 2022 | 372,000.00 |
| Jun 30, 2022 | 373,000.00 |
| Mar 31, 2022 | 354,000.00 |
| Dec 31, 2021 | 356,000.00 |
| Sep 30, 2021 | 355,698.00 |
| Jun 30, 2021 | 374,648.00 |